Brouet JC - Search Results

1

Arsenic trioxide is effective in the treatment of multiple myeloma in SCID mice.

Rousselot P, Larghero J, Labaume S, Poupon J, Chopin M, Dosquet C, Marolleau JP, Janin A, Brouet JC, Fermand JP. Rousselot P, et al. Among authors: brouet jc. Eur J Haematol. 2004 Mar;72(3):166-71. doi: 10.1046/j.0902-4441.2003.00194.x. Eur J Haematol. 2004. PMID: 14962234

2

Marrow transplantation for myeloma.

Fermand JP, Brouet JC. Fermand JP, et al. Among authors: brouet jc. Annu Rev Med. 1995;46:299-307. doi: 10.1146/annurev.med.46.1.299. Annu Rev Med. 1995. PMID: 7598466 Review.

3

Differential in vitro and in vivo effects of all-trans retinoic acid on the growth of human myeloma cells.

Labaume S, Chopin M, Pla M, Brouet JC. Labaume S, et al. Among authors: brouet jc. Leuk Lymphoma. 1998 Jul;30(3-4):361-6. doi: 10.3109/10428199809057547. Leuk Lymphoma. 1998. PMID: 9713966

4

Arsenic trioxide and melarsoprol induce apoptosis in plasma cell lines and in plasma cells from myeloma patients.

Rousselot P, Labaume S, Marolleau JP, Larghero J, Noguera MH, Brouet JC, Fermand JP. Rousselot P, et al. Among authors: brouet jc. Cancer Res. 1999 Mar 1;59(5):1041-8. Cancer Res. 1999. PMID: 10070961

5

Phase II trial of arsenic trioxide and alpha interferon in patients with relapsed/refractory adult T-cell leukemia/lymphoma.

Hermine O, Dombret H, Poupon J, Arnulf B, Lefrère F, Rousselot P, Damaj G, Delarue R, Fermand JP, Brouet JC, Degos L, Varet B, de Thé H, Bazarbachi A. Hermine O, et al. Among authors: brouet jc. Hematol J. 2004;5(2):130-4. doi: 10.1038/sj.thj.6200374. Hematol J. 2004. PMID: 15048063 Clinical Trial.

6

Phenotype and immunoglobulin gene configuration of blood B cells from patients with multiple myeloma.

Levy Y, Schmitt C, Tsapis A, Brouet JC, Fermand JP. Levy Y, et al. Among authors: brouet jc. Clin Exp Immunol. 1991 Jun;84(3):435-9. Clin Exp Immunol. 1991. PMID: 2044222 Free PMC article.

7

Differential effects of low and high concentrations of interleukin 6 on human B cells.

Levy Y, Fermand JP, Brouet JC. Levy Y, et al. Among authors: brouet jc. Eur J Immunol. 1990 Nov;20(11):2389-93. doi: 10.1002/eji.1830201105. Eur J Immunol. 1990. PMID: 2147647

8

Myeloma cell contamination of peripheral blood stem cell grafts in patients with multiple myeloma treated by high-dose therapy.

Mariette X, Fermand JP, Brouet JC. Mariette X, et al. Among authors: brouet jc. Bone Marrow Transplant. 1994 Jul;14(1):47-50. Bone Marrow Transplant. 1994. PMID: 7524906

9

Expression of GpIb on plasma cells in a patient with monoclonal IgG and acquired von Willebrand disease.

Scrobohaci ML, Daniel MT, Levy Y, Marolleau JP, Brouet JC. Scrobohaci ML, et al. Among authors: brouet jc. Br J Haematol. 1993 Jul;84(3):471-5. doi: 10.1111/j.1365-2141.1993.tb03103.x. Br J Haematol. 1993. PMID: 8217799

10

Retinoic acid modulates the in vivo and in vitro growth of IL-6 autocrine human myeloma cell lines via induction of apoptosis.

Levy Y, Labaume S, Colombel M, Brouet JC. Levy Y, et al. Among authors: brouet jc. Clin Exp Immunol. 1996 Apr;104(1):167-72. doi: 10.1046/j.1365-2249.1996.d01-637.x. Clin Exp Immunol. 1996. PMID: 8603522 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

282 results

Search Page

Filters